• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.催眠药物存在导致死亡、感染、抑郁和癌症的风险:但并无益处。
F1000Res. 2016 May 19;5:918. doi: 10.12688/f1000research.8729.3. eCollection 2016.
2
Zolpidem: Efficacy and Side Effects for Insomnia.唑吡坦:治疗失眠的疗效与副作用
Health Psychol Res. 2021 Jun 18;9(1):24927. doi: 10.52965/001c.24927. eCollection 2021.
3
What do hypnotics cost hospitals and healthcare?催眠药物给医院和医疗保健带来了怎样的成本?
F1000Res. 2017 Apr 21;6:542. doi: 10.12688/f1000research.11328.2. eCollection 2017.
4
Chronic hypnotic use: deadly risks, doubtful benefit. REVIEW ARTICLE.长期使用催眠药物:致命风险,益处存疑。综述文章。
Sleep Med Rev. 2000 Feb;4(1):5-20. doi: 10.1053/smrv.1999.0076.
5
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.心理治疗对长期使用催眠药物的失眠症的调节作用。
Health Technol Assess. 2004 Feb;8(8):iii-iv, 1-68. doi: 10.3310/hta8080.
6
An assessment of short-acting hypnotics.短效催眠药的评估。
Drug Saf. 1995 Oct;13(4):257-70. doi: 10.2165/00002018-199513040-00005.
7
[Management of insomnia: drug approach].[失眠的治疗:药物疗法]
Rev Prat. 2017 Oct;67(8):868-872.
8
Main neuroendocrine features and therapy in primary sleep troubles.原发性睡眠障碍的主要神经内分泌特征及治疗
Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):862-6.
9
The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use: A narrative review.认知行为疗法治疗失眠对镇静催眠药物使用的影响:叙事性综述。
Sleep Med Rev. 2021 Apr;56:101404. doi: 10.1016/j.smrv.2020.101404. Epub 2020 Dec 9.
10
Insomnia in the elderly: a review for the primary care practitioner.老年人失眠:初级保健医生综述
Sleep. 2000 Feb 1;23 Suppl 1:S23-30; discussion S36-8.

引用本文的文献

1
Efficacy and Tolerability of a Chemically Characterized L. Extract-Based Food Supplement for Sleep Management: A Single-Center, Controlled, Randomized, Crossover, Double-Blind Clinical Trial.一种基于化学特性明确的L.提取物的睡眠管理食品补充剂的疗效和耐受性:一项单中心、对照、随机、交叉、双盲临床试验。
Nutrients. 2025 Apr 28;17(9):1491. doi: 10.3390/nu17091491.
2
Perceived Stress and Clinical Insomnia in Primary Care: Associations with Lifestyle and Medication Use.基层医疗中感知到的压力与临床失眠:与生活方式和药物使用的关联。
Patient Prefer Adherence. 2025 May 5;19:1305-1316. doi: 10.2147/PPA.S524090. eCollection 2025.
3
Effects of Acute Aerobic Exercise Acute Zolpidem Intake on Sleep in Individuals with Chronic Insomnia.急性有氧运动与急性唑吡坦摄入对慢性失眠个体睡眠的影响。
Sleep Sci. 2024 Jun 5;18(1):e64-e73. doi: 10.1055/s-0044-1787530. eCollection 2025 Mar.
4
Effects of aromatherapy on sleep quality in older adults: A meta-analysis.芳香疗法对老年人睡眠质量的影响:一项荟萃分析。
Medicine (Baltimore). 2024 Dec 6;103(49):e40688. doi: 10.1097/MD.0000000000040688.
5
Progress in GABAA receptor agonists for insomnia disorder.用于失眠症的GABAA受体激动剂的研究进展。
Front Pharmacol. 2024 Nov 5;15:1432726. doi: 10.3389/fphar.2024.1432726. eCollection 2024.
6
[Sleep and sleep disorders in old age].[老年睡眠与睡眠障碍]
Z Gerontol Geriatr. 2024 Nov;57(7):569-577. doi: 10.1007/s00391-024-02363-8. Epub 2024 Oct 4.
7
Efficacy of eHealth Versus In-Person Cognitive Behavioral Therapy for Insomnia: Systematic Review and Meta-Analysis of Equivalence.电子健康与面对面认知行为疗法治疗失眠的疗效比较:等效性的系统评价和荟萃分析。
JMIR Ment Health. 2024 Aug 26;11:e58217. doi: 10.2196/58217.
8
Monitoring illicit pentobarbital availability in the United States: A National Drug Early Warning System briefing.监测美国非法戊巴比妥的供应情况:国家药物预警系统简报。
Drug Alcohol Depend. 2024 Oct 1;263:112402. doi: 10.1016/j.drugalcdep.2024.112402. Epub 2024 Aug 13.
9
The Triad of Sleep, Immunity, and Cancer: A Mediating Perspective.睡眠、免疫与癌症的三联体:一种中介视角。
Cells. 2024 Jul 24;13(15):1246. doi: 10.3390/cells13151246.
10
Herbal and Natural Supplements for Improving Sleep: A Literature Review.用于改善睡眠的草药和天然补充剂:文献综述
Psychiatry Investig. 2024 Aug;21(8):810-821. doi: 10.30773/pi.2024.0121. Epub 2024 Aug 2.

催眠药物存在导致死亡、感染、抑郁和癌症的风险:但并无益处。

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

作者信息

Kripke Daniel F

机构信息

University of California, San Diego, La Jolla, CA, 92037-2226, USA.

出版信息

F1000Res. 2016 May 19;5:918. doi: 10.12688/f1000research.8729.3. eCollection 2016.

DOI:10.12688/f1000research.8729.3
PMID:27303633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4890308/
Abstract

This is a review of hypnotic drug risks and benefits. Almost every month, new information appears about the risks of hypnotics (sleeping pills). The most important risks of hypnotics include excess mortality (especially overdose deaths, quiet deaths at night, and suicides), infections, cancer, depression, automobile crashes, falls, other accidents, and hypnotic-withdrawal insomnia. Short-term use of one-two prescriptions is associated with even greater risk per dose than long-term use. Hypnotics have usually been prescribed without approved indication, most often with specific contraindications, but even when indicated, there is little or no benefit. The recommended doses objectively increase sleep little if at all, daytime performance is often made worse (not better) and the lack of general health benefits is commonly misrepresented in advertising. Treatments such as the cognitive behavioral treatment of insomnia and bright light treatment of circadian rhythm disorders offer safer and more effective alternative approaches to insomnia.

摘要

这是一篇关于催眠药物风险与益处的综述。几乎每个月都会出现有关催眠药(安眠药)风险的新信息。催眠药最重要的风险包括额外死亡率(尤其是过量死亡、夜间安静死亡和自杀)、感染、癌症、抑郁症、汽车撞车事故、跌倒、其他事故以及催眠药戒断性失眠。短期使用一两剂处方催眠药,每剂的风险甚至比长期使用更大。催眠药通常是在没有获批适应症的情况下开具的,大多数情况下存在特定禁忌症,但即使有适应症,其益处也微乎其微或根本没有益处。推荐剂量实际上几乎没有增加睡眠时间,如果有的话,白天的表现往往会变差(而非变好),而且广告中常常错误地宣传其对整体健康没有益处。诸如失眠的认知行为疗法和昼夜节律紊乱的强光疗法等治疗方法为失眠提供了更安全、更有效的替代方法。